By taking this action, the Committee clearly recognizes the very real danger that these sweetheart deals pose to Americans struggling to pay their medical bills. Consumers must wait – sometimes years – for far less expensive generic drugs when branded pharmaceutical companies pay off their generic competitors to stay out of the market. We estimate that stopping these pay-for-delay settlements will save consumers about $3.5 billion per year and advance the cause of affordable health care for all Americans.
Let me commend the Senate Judiciary Committee and the leadership of Senator Kohl, Senator Grassley, and Chairman Leahy for all their efforts.
WASHINGTON—Acting Senior Deputy Comptroller and Chief Counsel Ted Dowd today testified on the Office of…
The Committee convened in a closed session at the Department of the Treasury at 9:00…
WASHINGTON — Today, the Department of the Treasury is taking action to further degrade Russia’s…
WASHINGTON – The final results from the annual survey of foreign portfolio holdings of U.S. securities at…
WASHINGTON – Today, the U.S. Department of the Treasury and White House convened a discussion…
As Prepared for DeliveryChairman Smith, Ranking Member Neal, and Members of the Committee: Thank you…